Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episo…
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers SquibbNCT06951711
Phase 3
A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)
This is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mania with mixed features in Bipolar-I diso…
Bipolar Disorder Type I With Mania
Bristol-Myers SquibbNCT06929273